CJC no DAC w/ Ipam is a combination of 2 (5mg) peptides for a total of 10mg formulated for precise applications. At Ultra Peps, we prioritize consistency, reliability, and research-focused handling standards.
CJC no DAC is frequently studied for its growth hormone-releasing hormone (GHRH) activity
Ipamorelin is frequently studied for its selective ghrelin receptor interaction
Trusted research supplier
Fast order processing
⚠️ Buy more and Save — price-per-vial table below. Quantity pricing can’t be combined with coupons; applying a coupon removes the quantity discount automatically.
CJC-1295 No DAC with Ipamorelin 5mg (each) is a peptide combination commonly studied for its interaction with growth hormone signaling pathways and endocrine response mechanisms. Additionally, researchers continue investigating this pairing because the two compounds work through different yet complementary pathways involved in endogenous growth hormone release.
CJC-1295 No DAC is commonly researched for its role as a growth hormone-releasing hormone (GHRH) analog, while Ipamorelin is frequently studied for its selective interaction with ghrelin receptors. Furthermore, the combination has become widely recognized in peptide research involving endocrine communication, metabolic signaling, and growth factor-related pathways. As a result, researchers frequently utilize this pairing to investigate coordinated hormone signaling and receptor-mediated biological responses.
Mode of Action
How CJC-1295 No DAC + Ipamorelin Is Modeled to Work
CJC-1295 No DAC functions as a growth hormone-releasing hormone (GHRH) analog that binds to GHRH receptors located on somatotroph cells within the anterior pituitary gland. Meanwhile, Ipamorelin selectively binds to growth hormone secretagogue receptors (GHS-R1a), also known as ghrelin receptors. As a result, both peptides stimulate growth hormone release through separate but complementary receptor pathways. This allows multiple endocrine signaling mechanisms to be activated simultaneously.
Furthermore, activation of GHRH and ghrelin receptor pathways produces coordinated intracellular signaling that influences growth hormone secretion and downstream endocrine communication.
Consequently, the released growth hormone interacts with target tissues and contributes to signaling pathways associated with insulin-like growth factor-1 (IGF-1), growth factor regulation, and metabolic communication networks. Because each peptide targets a distinct receptor system, the combination is frequently utilized to investigate receptor synergy, pulsatile hormone signaling, and endocrine pathway coordination.
Illustrative animation of pathways referenced in preclinical / in-vitro literature — not a claim of clinical effect.
GHRH Receptor Binding
Framed as the CJC-1295 No DAC component’s primary interaction — binding GHRH receptors on somatotroph cells within the anterior pituitary.
GHS-R1a Ghrelin Binding
Referenced in studies examining the Ipamorelin component’s selective binding to growth hormone secretagogue receptors (GHS-R1a).
Coordinated GH / IGF-1 Release
Associated with research into how the two complementary receptor pathways combine to produce coordinated growth-hormone secretion and downstream IGF-1 signaling.
Ipamorelin is one part of this blend. Therefore, researchers may compare the single compound with the blend to examine how paired signaling changes the research model.
CJC 1295 NO DAC provides the GHRH analog component of the blend. Additionally, scientists may compare it alone against the combined formula to study single-pathway versus dual-pathway activity.
CJC 1295 with DAC offers a longer-acting comparison in GHRH analog research. In simple terms, it helps researchers compare shorter-acting blend models with longer-duration peptide signaling.
Selected Literature
Published Research
Literature below covers the component peptides of this blend.
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research. It is to be handled by qualified and licensed professionals, in laboratory settings only.
Bodily introduction of any kind, into humans or animals, is strictly illegal by law. This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research. It is to be handled by qualified and licensed professionals, in laboratory settings only.
Bodily introduction of any kind, into humans or animals, is strictly illegal by law.This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
Each unit is prepared with attention to consistency. Packaging is sealed and reinforced to protect shipment integrity. In addition, we offer Protection Coverage at checkout as an additional option which covers lost or damaged packages ($3.99). We’ll re-ship or refund eligible orders once confirmed. For additional information please visit our Shipping Policy and tracking Info Page
We ship USPS Priority only
Ships same day M-F (before 4pm est cutoff)
Orders placed on a Federal holiday or weekend will be delivered on the next business day
Free shipping on orders over $150. This offer will be available based on post-discount order amount
Signature confirmation is offered at checkout for $19.99
Tracking & Insurance (up to $100 via USPS) is included
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research. It is to be handled by qualified and licensed professionals, in laboratory settings only.
Bodily introduction of any kind, into humans or animals, is strictly illegal by law.This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
I. RESEARCH USE ONLY: Products are sold strictly for laboratory research and in-vitro testing, not for human or animal use. II. ASSUMPTION OF RISK: You assume all risk associated with these chemicals. III. LIABILITY: You agree to indemnify BCUltra LLC for any misuse, including human consumption. IV. COMPLIANCE: You certify you are 21+ & will handle these peptides & chems per all applicable law.
0 items
New here? Take 10% OFF your first order with code WELCOME10 at checkout.
CJC no DAC w/ Ipamorelin 5mg
$59.99
CJC no DAC w/ Ipam is a combination of 2 (5mg) peptides for a total of 10mg formulated for precise applications. At Ultra Peps, we prioritize consistency, reliability, and research-focused handling standards.
⚠️ Buy more and Save — price-per-vial table below. Quantity pricing can’t be combined with coupons; applying a coupon removes the quantity discount automatically.
🔒Payments Accepted
Product images are for illustration purposes only.
Description
Overview
CJC-1295 No DAC + Ipamorelin Research Compound
CJC-1295 No DAC with Ipamorelin 5mg (each) is a peptide combination commonly studied for its interaction with growth hormone signaling pathways and endocrine response mechanisms. Additionally, researchers continue investigating this pairing because the two compounds work through different yet complementary pathways involved in endogenous growth hormone release.
CJC-1295 No DAC is commonly researched for its role as a growth hormone-releasing hormone (GHRH) analog, while Ipamorelin is frequently studied for its selective interaction with ghrelin receptors. Furthermore, the combination has become widely recognized in peptide research involving endocrine communication, metabolic signaling, and growth factor-related pathways. As a result, researchers frequently utilize this pairing to investigate coordinated hormone signaling and receptor-mediated biological responses.
Mode of Action
How CJC-1295 No DAC + Ipamorelin Is Modeled to Work
CJC-1295 No DAC functions as a growth hormone-releasing hormone (GHRH) analog that binds to GHRH receptors located on somatotroph cells within the anterior pituitary gland. Meanwhile, Ipamorelin selectively binds to growth hormone secretagogue receptors (GHS-R1a), also known as ghrelin receptors. As a result, both peptides stimulate growth hormone release through separate but complementary receptor pathways. This allows multiple endocrine signaling mechanisms to be activated simultaneously.
Furthermore, activation of GHRH and ghrelin receptor pathways produces coordinated intracellular signaling that influences growth hormone secretion and downstream endocrine communication.
Consequently, the released growth hormone interacts with target tissues and contributes to signaling pathways associated with insulin-like growth factor-1 (IGF-1), growth factor regulation, and metabolic communication networks. Because each peptide targets a distinct receptor system, the combination is frequently utilized to investigate receptor synergy, pulsatile hormone signaling, and endocrine pathway coordination.
Illustrative animation of pathways referenced in preclinical / in-vitro literature — not a claim of clinical effect.
GHRH Receptor Binding
Framed as the CJC-1295 No DAC component’s primary interaction — binding GHRH receptors on somatotroph cells within the anterior pituitary.
GHS-R1a Ghrelin Binding
Referenced in studies examining the Ipamorelin component’s selective binding to growth hormone secretagogue receptors (GHS-R1a).
Coordinated GH / IGF-1 Release
Associated with research into how the two complementary receptor pathways combine to produce coordinated growth-hormone secretion and downstream IGF-1 signaling.
Chemical Details
Structure & Properties
2D ANIMATION
Illustrative molecular-assembly animation (generic structural reference).
Research Scope
What CJC-1295 No DAC + Ipamorelin Is Researched For
Researchers continue evaluating this peptide blend across multiple scientific disciplines involving hormonal regulation and metabolic signaling.
Framed as a primary research focus for the blend, examining coordinated growth hormone release from the anterior pituitary.
Referenced in studies examining pituitary-level signaling and broader endocrine pathway coordination.
Associated with research into GHS-R1a (ghrelin receptor) activation and its role in the Ipamorelin component’s mechanism.
Explored in recovery and tissue-support models, including cellular repair and regenerative signaling investigations.
Investigated in studies of metabolic signaling and nutrient-partitioning pathways linked to growth hormone activity.
Framed as a reference blend for research into body composition changes and broader hormone-response patterns.
Related Research
Related Research Compounds
Ipamorelin 5mg
Ipamorelin is one part of this blend. Therefore, researchers may compare the single compound with the blend to examine how paired signaling changes the research model.
CJC 1295 NO DAC 5mg
CJC 1295 NO DAC provides the GHRH analog component of the blend. Additionally, scientists may compare it alone against the combined formula to study single-pathway versus dual-pathway activity.
CJC 1295 with DAC 5mg
CJC 1295 with DAC offers a longer-acting comparison in GHRH analog research. In simple terms, it helps researchers compare shorter-acting blend models with longer-duration peptide signaling.
Selected Literature
Published Research
Literature below covers the component peptides of this blend.
Further Reading
This Product Is For Research Only
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research. It is to be handled by qualified and licensed professionals, in laboratory settings only.
Bodily introduction of any kind, into humans or animals, is strictly illegal by law. This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
Please read our Terms and Conditions prior to ordering.
THIS PRODUCT IS FOR RESEARCH ONLY
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research. It is to be handled by qualified and licensed professionals, in laboratory settings only.
Bodily introduction of any kind, into humans or animals, is strictly illegal by law.This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
Please read our Terms and Conditions prior to ordering.
Additional information
Solid (Powder)
White
5mg
peptide analogue of growth hormone-releasing hormone (GHRH)
Research Peptide
Ultra Peps
Each unit is prepared with attention to consistency. Packaging is sealed and reinforced to protect shipment integrity. In addition, we offer Protection Coverage at checkout as an additional option which covers lost or damaged packages ($3.99). We’ll re-ship or refund eligible orders once confirmed. For additional information please visit our Shipping Policy and tracking Info Page
THIS PRODUCT IS FOR RESEARCH ONLY
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research. It is to be handled by qualified and licensed professionals, in laboratory settings only.
Bodily introduction of any kind, into humans or animals, is strictly illegal by law.This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
Please read our Terms and Conditions prior to ordering.
Certificate of Analysis
View the Certificate of Analysis for this batch, provided by our testing lab.
Download COA (PDF)
You may also like…
Ipamorelin 5mg
$32.99 Add to cartCJC 1295 NO DAC 5mg
$36.99 Add to cartGHRP 2 5mg
$19.99 Add to cartHGH Fragment 176-191 5mg
$44.99 Add to cartCJC 1295 with DAC 5mg
$43.99 Add to cartIGF 1 DES 1mg
$59.99 Add to cartGHRP 6 5mg
$19.99 Add to cartRelated products
Acetic Acid 0.6%
$15.99 Add to cartMyostatin 1mg
$99.99 Read moreSelank 10mg
$41.99 Add to cartP21 50mg
$109.99 Add to cart